Monthly Archives: July 2015

Trials and Tribulations: The Prevention of Variceal Rebleeding

The last 25 years of portal hypertension clinical research has directly resulted in a reduction in variceal bleeding mortality from 50% to 20%. This research has included introduction of new techniques, technological refinements, and application of old… Continue reading

Posted in News | Comments Off on Trials and Tribulations: The Prevention of Variceal Rebleeding

c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer

Studies to identify the cells that fuel colorectal cancer (CRC) cell renewal and metastasis have shown that such behavior is enriched in a subpopulation of cells with stem cell-like features or tumor-initiating cells. The identification of drugs that t… Continue reading

Posted in News | Comments Off on c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer

c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer

Studies to identify the cells that fuel colorectal cancer (CRC) cell renewal and metastasis have shown that such behavior is enriched in a subpopulation of cells with stem cell-like features or tumor-initiating cells. The identification of drugs that t… Continue reading

Posted in News | Comments Off on c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer

Lack of Survival Benefit following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice

The ever-increasing success of liver transplantation as a life-saving procedure has led to the demand for donor organs far outstripping supply. Nearly 1 in 5 patients waiting for a liver transplant in the United States dies before an organ becomes avai… Continue reading

Posted in News | Comments Off on Lack of Survival Benefit following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice

Lack of Survival Benefit following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice

The ever-increasing success of liver transplantation as a life-saving procedure has led to the demand for donor organs far outstripping supply. Nearly 1 in 5 patients waiting for a liver transplant in the United States dies before an organ becomes avai… Continue reading

Posted in News | Comments Off on Lack of Survival Benefit following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice

The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”

The liver possesses an extraordinary regenerative capacity that is triggered upon death of parenchymal cells or after partial liver resection. This fundamental response likely evolved to protect the organ and the organism from endogenous and exogenous … Continue reading

Posted in News | Comments Off on The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”

The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”

The liver possesses an extraordinary regenerative capacity that is triggered upon death of parenchymal cells or after partial liver resection. This fundamental response likely evolved to protect the organ and the organism from endogenous and exogenous … Continue reading

Posted in News | Comments Off on The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”

Professor Claude C. Roy, October 21,1928–July 2, 2015

Claude Roy, the eminent Canadian physician and scientist, considered one of the founders of pediatric gastroenterology, died in Montreal on July 2, 2015 at the age of 86. He leaves behind a profound and lasting impression upon the spirit of those that … Continue reading

Posted in News | Comments Off on Professor Claude C. Roy, October 21,1928–July 2, 2015

Professor Claude C. Roy, October 21,1928–July 2, 2015

Claude Roy, the eminent Canadian physician and scientist, considered one of the founders of pediatric gastroenterology, died in Montreal on July 2, 2015 at the age of 86. He leaves behind a profound and lasting impression upon the spirit of those that … Continue reading

Posted in News | Comments Off on Professor Claude C. Roy, October 21,1928–July 2, 2015

Exam 3: Comparison of Liver Transplant-related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States

Posted in News | Comments Off on Exam 3: Comparison of Liver Transplant-related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States